These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31676919)

  • 1. Continuous production of Neisseria meningitidis outer membrane vesicles.
    Gerritzen MJH; Stangowez L; van de Waterbeemd B; Martens DE; Wijffels RH; Stork M
    Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9401-9410. PubMed ID: 31676919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
    Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
    Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane vesicles (OMV) production of Neisseria meningitidis serogroup B in batch process.
    Santos S; Arauz LJ; Baruque-Ramos J; Lebrun I; Carneiro SM; Barreto SA; Schenkman RP
    Vaccine; 2012 Sep; 30(42):6064-9. PubMed ID: 22867717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.
    Gerritzen MJH; Martens DE; Uittenbogaard JP; Wijffels RH; Stork M
    Sci Rep; 2019 Mar; 9(1):4716. PubMed ID: 30886228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane vesicles as platform vaccine technology.
    van der Pol L; Stork M; van der Ley P
    Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
    Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.
    Quakyi EK; Hochstein HD; Tsai CM
    Infect Immun; 1997 May; 65(5):1972-9. PubMed ID: 9125592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory.
    Izeli Portilho A; Araujo Correa V; Dos Santos Cirqueira C; De Gaspari E
    Immunol Invest; 2022 Oct; 51(7):2066-2085. PubMed ID: 35950702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System.
    Hekmat S; Sadat SM; Aslani MM; Mahdavi M; Bolhassani A; Asgar Halvaee F; Ghahari SMM; Aghasadeghi MR; Siadat SD
    Iran Biomed J; 2019 Jul; 23(4):235-45. PubMed ID: 30278608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex.
    Fu J; Bailey FJ; King JJ; Parker CB; Robinett RS; Kolodin DG; George HA; Herber WK
    Biotechnology (N Y); 1995 Feb; 13(2):170-4. PubMed ID: 9634759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid response to SARS-CoV-2 and
    Portilho AI; Hermes Monteiro da Costa H; Grando Guereschi M; Prudencio CR; De Gaspari E
    Hum Vaccin Immunother; 2024 Dec; 20(1):2346963. PubMed ID: 38745461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Membrane Vesicle Vaccine Platforms.
    Micoli F; Adamo R; Nakakana U
    BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack.
    Dehinwal R; Cooley D; Rakov AV; Alugupalli AS; Harmon J; Cunrath O; Vallabhajosyula P; Bumann D; Schifferli DM
    mBio; 2021 Jun; 12(3):e0086921. PubMed ID: 34061589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
    Sanders H; Feavers IM
    Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.
    van de Waterbeemd B; Zomer G; Kaaijk P; Ruiterkamp N; Wijffels RH; van den Dobbelsteen GP; van der Pol LA
    PLoS One; 2013; 8(5):e65157. PubMed ID: 23741478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.